Diversified Healthcare Trust (NASDAQ:DHC) has been given a consensus recommendation of “Hold” by the seven ratings firms that are currently covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $4.25.
Several equities research analysts have recently commented on DHC shares. Zacks Investment Research downgraded Diversified Healthcare Trust from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 26th. B. Riley upped their price target on Diversified Healthcare Trust from $5.00 to $6.00 and gave the company a “buy” rating in a research report on Monday, March 1st. Morgan Stanley upped their price target on Diversified Healthcare Trust from $4.75 to $5.00 and gave the company an “equal weight” rating in a research report on Monday, March 22nd. Finally, Wells Fargo & Company lowered Diversified Healthcare Trust from an “equal weight” rating to an “underweight” rating and set a $4.00 price target on the stock. in a research report on Thursday, December 10th.
A number of hedge funds have recently modified their holdings of the business. Everence Capital Management Inc. acquired a new position in Diversified Healthcare Trust in the 1st quarter worth about $315,000. Pensionfund DSM Netherlands increased its position in Diversified Healthcare Trust by 33.4% in the 1st quarter. Pensionfund DSM Netherlands now owns 399,100 shares of the real estate investment trust’s stock worth $1,908,000 after purchasing an additional 100,000 shares during the last quarter. Pensionfund Sabic increased its position in Diversified Healthcare Trust by 11.7% in the 1st quarter. Pensionfund Sabic now owns 143,100 shares of the real estate investment trust’s stock worth $684,000 after purchasing an additional 15,000 shares during the last quarter. Norges Bank acquired a new position in Diversified Healthcare Trust in the 4th quarter worth about $13,066,000. Finally, UBS Asset Management Americas Inc. increased its position in Diversified Healthcare Trust by 22.3% in the 4th quarter. UBS Asset Management Americas Inc. now owns 1,232,038 shares of the real estate investment trust’s stock worth $5,076,000 after purchasing an additional 224,513 shares during the last quarter. 74.64% of the stock is currently owned by institutional investors.
Diversified Healthcare Trust (NASDAQ:DHC) last announced its earnings results on Wednesday, February 24th. The real estate investment trust reported ($0.07) EPS for the quarter, missing the consensus estimate of $0.05 by ($0.12). Diversified Healthcare Trust had a negative net margin of 11.64% and a negative return on equity of 6.33%. As a group, sell-side analysts expect that Diversified Healthcare Trust will post 0.63 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, February 18th. Shareholders of record on Monday, January 25th were given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.83%. The ex-dividend date was Friday, January 22nd. Diversified Healthcare Trust’s payout ratio is currently 3.05%.
About Diversified Healthcare Trust
DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc, an alternative asset management company that is headquartered in Newton, MA.
Recommended Story: What is a front-end load?
Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.